8:00 am Registration & Welcome Coffee

8:45 am Chair’s Opening Remarks

• Amir Lahav Head of Strategic R&D, Digital Health Innovation & Corporate Strategy, Mitsubishi Tanabe Pharma America

DEFINING BUSINESS MODELS TO HARNESS PAYMENT OPPORTUNITIES

9:00 am OPENING PANEL: Choosing a Business Model to Bring Your Digital Health Solution to Market

• John Drakenberg CEO, Alex Therapeutics
• Doug Biehn CCO, Cala Health
• Ivar Meyvantsson VP, Product Development and Strategy, Sidekick Health

9:30 am How to Convince Investors, Payers, and Patients Your Digital Health Solution is Worth the Cost

• Laura Yecies CEO, Bone Health Technologies

10:00 am PANEL DISCUSSION: Striking Strategic Partnerships with Payers for Commercial Success

• Everett Crosland CCO, Cognito Therapeutics
• Brad Gescheider CCO, Woebot Health

10:30 am Speed Networking and Morning Coffee Break

11:30 am PANEL DISCUSSION: Coding, Coverage and Payment – The Steps to Commercialization with Pear Therapeutics

• Andy Molnar CEO, The Digital Therapeutics Alliance
• Beth Keyt VP, Government Affairs, Pear Therapeutics
• Mark Hopman VP, Market Access, Pear Therapeutics

12:15 pm PANEL DISCUSSION: Establishing Mutually Beneficial Partnerships with Employers

• Innocent Clement CEO, Ciba Health
• Christopher Lento Head of Healthcare Sales and Partnerships, Noom

1:00 pm Networking Lunch Break

2:00 pm Interactive Discussion Groups

2:30 pm Connected Health Solutions: Satisfying the Needs of Patients, Healthcare Professionals and Regulators

• Emilia Kruzel Director, Business Development , Propeller Health

3:00 pm PANEL DISCUSSION: Looking Into The Minds of Investors and Partners for Understanding Key Characteristics to Secure Investment

• Pavan Choksi Partner, Arkitekt Ventures
• Rachel Sha Executive in Residence, The Engine

3:30 pm Afternoon Break & Networking Coffee

DEVELOPMENT STAGE STRATEGIES TO INFORM FUTURE SUCCESS

4:00 pm PANEL DISCUSSION: Designing Clinical Trials for Digital Health Solutions to Achieve FDA Clearance and Ensure Future Commercial Success

• Whitney Stewart Director of Clinical Project Managment, Curebase

4:30 pm A Breath of Fresh Air: How Decentralised Clinical Trial Options are Changing Respiratory Clinical Development

• Yury Rozenman SVP, Business Development, Propeller Health

5:00 pm Chair’s Closing Remarks

• Amir Lahav Head of Strategic R&D, Digital Health Innovation & Corporate Strategy, Mitsubishi Tanabe Pharma America